In a retrospective series of 8 patients with primary cardiac sarcoma, surgery combined with postoperative radiotherapy was feasible and resulted in a mean survival of 38 months.
Case Report (n=8)
Yes
Surgery combined with postoperative radiotherapy is feasible for resectable primary cardiac sarcoma, but the prognosis remains poor due to frequent distant metastases.
BACKGROUND: Primary cardiac tumors are extremely rare. Most primary cardiac tumors are benign and around one quarter is malign. Sarcomas are accounting for 95% of these malign tumors and they show different histologies. The prognosis is poor with a mean survival of 3 months to 1 year, even with complete radical resection. We report the cases of two patients with primary cardiac sarcoma treated with surgery and radiation and/or chemotherapy. In addition we retrospectively collected data of patients with primary cardiac sarcoma treated between 2005 and 2019 with minimum follow-up of 12 months. Clinical characteristics, treatment modalities and outcomes were collected and analyzed. Finally a literature review was done. CASE PRESENTATION: The first patient presented with cerebellar infarction. When she developed a recurrence analysis showed a suspicious myocardial lesion for which irradical surgery (R2) was performed. Histopathology showed an intimal sarcoma of the left atrium. Postoperative radiotherapy was applied without complications. Three months after treatment multiple metastases were diagnosed and she died 13 months after initial diagnosis. The second patient presented with pericardial effusion. A tumor was found located in the right atrium and radical surgery was performed. Histopathology showed an angiosarcoma, without signs of metastases. Adjuvant radiotherapy was added because of close margins and based on high risk of recurrence and metastases it was decided to add chemotherapy. One year after finishing treatment, evaluation showed local recurrence together with pulmonary metastases. CONCLUSIONS: Surgery combined with postoperative radiotherapy is feasible in patients with resectable cardiac sarcoma. Distant metastases occur frequently. In patients with an irresectable sarcoma of the heart primary radiotherapy should be considered.
Moeri-Schimmel et al. (Tue,) conducted a case report in Primary cardiac sarcoma (n=8). Surgery and adjuvant radiotherapy or chemotherapy was evaluated on Survival. In a retrospective series of 8 patients with primary cardiac sarcoma, surgery combined with postoperative radiotherapy was feasible and resulted in a mean survival of 38 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: